Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome
Top Cited Papers
Open Access
- 2 September 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (9) , 2926-2935
- https://doi.org/10.1002/art.21250
Abstract
Objective: Churg‐Strauss syndrome (CSS) is classified among the so‐called antineutrophil cytoplasmic antibody–associated systemic vasculitides (AASVs) because of its clinicopathologic features that overlap with the other AASVs. However, while antineutrophil cytoplasmic antibodies (ANCAs) are consistently found in 75–95% of patients with Wegener's granulomatosis or microscopic polyangiitis, their prevalence in CSS varies widely and their clinical significance remains uncertain. We undertook this study to examine the prevalence and antigen specificity of ANCAs in a large cohort of patients with CSS. Moreover, we evaluated the relationship between ANCA positivity and clinicopathologic features.Methods: Immunofluorescence and enzyme‐linked immunosorbent assay were used to determine the presence or absence of ANCAs in 93 consecutive patients at the time of diagnosis. The main clinical and pathologic data, obtained by retrospective analysis, were correlated with ANCA status.Results: ANCAs were present by immunofluorescence in 35 of 93 patients (37.6%). A perinuclear ANCA (pANCA) pattern was found in 26 of 35 patients (74.3%), with specificity for myeloperoxidase (MPO) in 24 patients, while a cytoplasmic ANCA pattern, with specificity for proteinase 3, was found in 3 of 35 patients (8.6%). Atypical patterns were found in 6 of 30 patients with anti‐MPO antibodies (20.0%). ANCA positivity was associated with higher prevalences of renal disease (51.4% versus 12.1%; P < 0.001) and pulmonary hemorrhage (20.0% versus 0.0%; P = 0.001) and, to a lesser extent, with other organ system manifestations (purpura and mononeuritis multiplex), but with lower frequencies of lung disease (34.3% versus 60.3%; P = 0.019) and heart disease (5.7% versus 22.4%; P = 0.042).Conclusion: ANCAs are present in ∼40% of patients with CSS. A pANCA pattern with specificity for MPO is found in most ANCA‐positive patients. ANCA positivity is mainly associated with glomerular and alveolar capillaritis.Keywords
This publication has 41 references indexed in Scilit:
- MPO-ANCA may produce a combination of P-ANCA and atypical cytoplasmic ANCA indirect immunofluorescent patterns on certain ethanol fixed neutrophil substratesJournal of Clinical Pathology, 2001
- Epidemiology of systemic vasculitis: A ten-year study in the United KingdomArthritis & Rheumatism, 2000
- Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studiesPharmacoepidemiology and Drug Safety, 1999
- Nonasthmatic Case of Churg-Strauss Syndrome with Rapidly Progressive Glomerulonephritis.Internal Medicine, 1998
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA patternClinical and Experimental Immunology, 1994
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Acute Renal Failure in a Patient Affected with Churg and Strauss SyndromeNephron, 1991
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988